Lack of direct role of parkin in the steady-state level and aggregation of α-synuclein and the clearance of pre-formed aggregates

Experimental Neurology

Volumn 197, Issue 2, 2006, Pages 538-541

  Kim, Yoon Suk ^a   Patel, Smita ^a   Lee, Seung Jae ^a  

^a PARKINSON S INSTITUTE   (United States)

Author keywords

synuclein; Adenoviral vector; Parkin; Parkinson's disease; Protein aggregation; RNA interference

Indexed keywords

ADENOVIRUS VECTOR; ALPHA SYNUCLEIN; PARKIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; STEADY STATE;

ALPHA-SYNUCLEIN; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CYSTEINE PROTEINASE INHIBITORS; GENE EXPRESSION; HUMANS; LEUPEPTINS; NEUROBLASTOMA; RNA, SMALL INTERFERING; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES;

EID: 30444432079     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2005.10.024     Document Type: Article

References (13)

1. K.K. Chung, Y. Zhang, K.L. Lim, Y. Tanaka, H. Huang, J. Gao, C.A. Ross, V.L. Dawson, and T.M. Dawson Parkin ubiquitinates the alpha-synuclein- interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease Nat. Med. 7 2001 1144 1150
2. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909
3. M.B. Feany, and L.J. Pallanck Parkin: a multipurpose neuroprotective agent? Neuron 38 2003 13 16
4. B.I. Giasson, and V.M. Lee Parkin and the molecular pathways of Parkinson's disease Neuron 31 2001 885 888
5. M. Goedert Alpha-synuclein and neurodegenerative diseases Nat. Rev., Neurosci. 2 2001 492 501
6. M.S. Goldberg, S.M. Fleming, J.J. Palacino, C. Cepeda, H.A. Lam, A. Bhatnagar, E.G. Meloni, N. Wu, L.C. Ackerson, G.J. Klapstein, M. Gajendiran, B.L. Roth, M.F. Chesselet, N.T. Maidment, M.S. Levine, and J. Shen Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons J. Biol. Chem. 278 2003 43628 43635
7. S.J. Kim, J.Y. Sung, J.W. Um, N. Hattori, Y. Mizuno, K. Tanaka, S.R. Paik, J. Kim, and K.C. Chung Parkin cleaves intracellular alpha-synuclein inclusions via the activation of calpain J. Biol. Chem. 278 2003 41890 41899
8. H.-J. Lee, F. Khoshaghideh, S. Patel, and S.-J. Lee Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway J. Neurosci. 24 2004 1888 1896
9. E. Maries, B. Dass, T.J. Collier, J.H. Kordower, and K. Steece-Collier The role of alpha-synuclein in Parkinson's disease: insights from animal models Nat. Rev., Neurosci. 4 2003 727 738
10. Y. Oluwatosin-Chigbu, A. Robbins, C.W. Scott, J.L. Arriza, J.D. Reid, and J.R. Zysk Parkin suppresses wild-type alpha-synuclein-induced toxicity in SH SY5Y cells Biochem. Biophys. Res. Commun. 309 2003 679 684
11. F.A. Perez, and R.D. Palmiter Parkin-deficient mice are not a robust model of parkinsonism Proc. Natl. Acad. Sci. U. S. A. 102 2005 2174 2179
12. H. Shimura, M.G. Schlossmacher, N. Hattori, M.P. Frosch, A. Trockenbacher, R. Schneider, Y. Mizuno, K.S. Kosik, and D.J. Selkoe Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease Science 293 2001 263 269
13. M.G. Spillantini, R.A. Crowther, R. Jakes, M. Hasegawa, and M. Goedert alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies Proc. Natl. Acad. Sci. U. S. A. 95 1998 6469 6473